FDA accepts tavaborole NDA

Anacor Pharmaceuticals Inc. (NASDAQ:ANAC) said late Tuesday that FDA accepted an NDA for tavaborole to treat onychomycosis. The PDUFA date is July 29, 2014. Tavaborole is a topical antifungal agent. A...